Amanda Dehn
Nurse Practitioner · South Bend, INNPI 1174984413
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 24.4% of the total. Reporting peaked in 2024 at $2,706 and has fallen 93.1% since, to $187 in 2025. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $40.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$974
- Crossroads Orthopedics, LLC$734
- Arthrex$460
- AbbVie$307
- Supernus Pharmaceuticals, Inc.$280
- Medical Device Business Services, Inc.$143
- plus $1K from 26 others
What the payments were for
- Travel & lodging$1,65542%
- Food & beverage$2,23156%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $974 |
| Crossroads Orthopedics, LLC | 4 | $734 |
| Arthrex | 11 | $460 |
| AbbVie | 16 | $307 |
| Supernus Pharmaceuticals, Inc. | 2 | $280 |
| Medical Device Business Services, Inc. | 2 | $143 |
| Johnson & Johnson(2 entities) | 2 | $130 |
| Novo Nordisk | 6 | $115 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Lilly USA, LLC | 5 | $76 |
| Stryker | 1 | $66 |
| Orthofix Medical, Inc. | 4 | $58 |
| AstraZeneca | 4 | $56 |
| Boehringer Ingelheim | 3 | $42 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $41 |
| Amgen | 3 | $41 |
| Merck | 2 | $39 |
| Exact Sciences | 2 | $39 |
| Corium, LLC | 2 | $37 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| GSK | 2 | $31 |
| Bayer | 2 | $30 |
| Astellas Pharma US Inc | 2 | $27 |
| Alvogen Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| MF MED | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,984 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 86 | $2,250 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 183 | $1,342 |
| Ondansetron Hcl | 154 | $1,206 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $559 |
| Cephalexin | 180 | $553 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $340 |
| Diclofenac Sodium | 21 | $251 |
| Tramadol Hcl | 44 | $162 |
| Methylprednisolone | 22 | $161 |
| Mupirocin | 26 | $159 |
| Amlodipine Besylate | 15 | $91 |
| Chlorhexidine Gluconate | 25 | $71 |
| Levothyroxine Sodium | 13 | $70 |
| Glycopyrrolate | 11 | $60 |
| Gabapentin | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in South Bend
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.